Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells

Anticancer Research

Volumn 33, Issue 12, 2013, Pages 5325-5334

  Moseley, Vondina R ^a   Morris, Jay ^b   Knackstedt, Rebecca W ^a   Wargovich, Michael J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Colon cancer; DNMT3A; EGCG; Epigallocatechin 3 gallate; Epigenetics; Green tea; HDAC3

Indexed keywords

ANTINEOPLASTIC AGENT; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EPIGALLOCATECHIN GALLATE; HISTONE DEACETYLASE 3; HOMEODOMAIN PROTEIN; MESSENGER RNA; UBIQUITIN LIKE CONTAINING PLANT HOMEO DOMAIN AND FINGER DOMAIN 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HCT116; COLON CANCER; DEGRADATION; DNA METHYLATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TEA;

EID: 84891410722     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ahmad N, Cheng P and Mukhtar H: Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275: 328-334, 2000.
2. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
3. Blum W, Klisovic RB, Hackanson B, Liu Z, Liu S, Devine H, Vukosavljevic T, Huynh L, Lozanski G, Kefauver C, Plass C, Devine SM, Heerema NA, Murgo A, Chan KK, Grever MR, Byrd JC and Marcucci G: Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 25: 3884-3891, 2007.
4. Borutinskaite VV, Magnusson KE and Navakauskiene R: Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells. Molec Biol Rep 2012.
5. Counts JL and Goodman JI: Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83: 13-15, 1995.
6. Fang M, Chen D and Yang CS: Dietary polyphenols may affect DNA methylation. Journal Nutrition 137: 223S-228S, 2007.
7. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570, 2003.
8. Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablon DM and You L: Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res 29: 2025-2030, 2009.
9. Gilbert ER and Liu D: Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure - Function Relationships and the Therapeutic Potential for Cancer. Curr Med Chem 2010.
10. Issa AY, Volate SR, Muga SJ, Nitcheva D, Smith T and Wargovich MJ: Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Carcinogenesis 28: 1978-1984, 2007.
11. Issa AY, Volate SR, Muga SJ, Nitcheva D, Smith T and Wargovich MJ: Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Carcinogenesis 28: 1978-1984, 2007.
12. Jia XD and Han C: Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats. World Journal of Gastroenterology 6: 699-703, 2000.
13. Jin JS, Tsao TY, Sun PC, Yu CP and Tzao C: SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Pathology oncology research: POR 18: 713-720, 2012.
14. Jones PA: DNA methylation and cancer. Oncogene 21: 5358-5360, 2002.
15. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nature reviews Genetics 3: 415-428, 2002.
16. Lee WJ, Shim JY and Zhu BT: Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Molec Pharmacol 68: 1018-1030, 2005.
17. Lynch HT and Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149-1167, 1996.
18. Nandakumar V, Vaid M and Katiyar SK: (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16 INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32: 537-544, 2011.
19. Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M, Heath JK, Ward RL, Waring PM and Ernst M: Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. Gastroenterology 137: 902-913, 913 e901-911, 2009.
20. Shimizu M, Deguchi A, Joe AK, McKoy JF, Moriwaki H and Weinstein IB: EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exper Therapeutics & Oncol 5: 69-78, 2005.
21. Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y and Moriwaki H: (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chemico-biological Interactions 185: 247-252, 2010.
22. Thakur VS, Gupta K and Gupta S: Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol 41: 353-361, 2012.
23. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP and Maheshwari RK: Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245: 232-241, 2007.
24. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
25. Volate SR, Muga SJ, Issa AY, Nitcheva D, Smith T and Wargovich MJ: Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Molec Carcinogenesis 48: 920-933, 2009.
26. Vu HA, Beppu Y, Chi HT, Sasaki K, Yamamoto H, Xinh PT, Tanii T, Hara Y, Watanabe T, Sato Y and Ohdomari I: Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor. J Biomedicine & Biotechnology 2010: 290516, 2010.
27. Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y and Qin HL: UHRF1 promotes cell growth and metastasis through repression of p16(ink(4)a) in colorectal cancer. Ann Surg Oncol 19: 2753-2762, 2012.
28. Wilson AJ, Byun DS, Popova N, Murray LB, L'Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH and Mariadason JM: Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281: 13548- 13558, 2006.
29. Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT and Zheng W: Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol, Biomarkers & Prevention 16: 1219-1223, 2007.
30. Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V and Al-Hendy A: Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertility Sterility 94: 1887-1893, 2010.
31. Zhang J, Gao Q, Li P, Liu X, Jia Y, Wu W, Li J, Dong S, Koseki H and Wong J: S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res 21: 1723-1739, 2011.
32. Zhang X, Min KW, Wimalasena J and Baek SJ: Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate. J Cancer Res Clin Oncol 138: 2051-2060, 2012.
33. Zhou L and Elias RJ: Antioxidant and pro-oxidant activity of (-)-epigallocatechin-3-gallate in food emulsions: Influence of pH and phenolic concentration. Food Chem 138: 1503-1509, 2013.